PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Vascalpha
Presentation Product Chemical substance Chapter Items dispensed
Vascalpha 10mg modified-release tablets (Accord)
0206020F0BIABAC
Vascalpha Felodipine Cardiovascular System 8,528
Vascalpha 5mg modified-release tablets (Accord)
0206020F0BIAAAB
Vascalpha Felodipine Cardiovascular System 8,213
Vascalpha 5mg modified-release tablets (Almus)
0206020F0BIACAB
Vascalpha Felodipine Cardiovascular System 3
Vascalpha 5mg modified-release tablets (NorthStar)
0206020F0BIAEAB
Vascalpha Felodipine Cardiovascular System 3
Vascalpha 10mg modified-release tablets (NorthStar)
0206020F0BIAFAC
Vascalpha Felodipine Cardiovascular System 1
Vascalpha 10mg modified-release tablets (Almus)
0206020F0BIADAC
Vascalpha Felodipine Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.